JILL SHIRLEY: Open Payments
NPI 1124682315 · GREENWOOD, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,523 in 149 payments from 22 companies in 2025. Trend: 2023 $2,093 · 2024 $2,481 · 2025 $3,523
Food & beverage: $3,455Education: $68
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 16 | $644 |
| AstraZeneca Pharmaceuticals LP | 22 | $491 |
| United Therapeutics Corporation | 13 | $418 |
| Verona Pharma, Inc. | 23 | $383 |
| GlaxoSmithKline, LLC. | 20 | $285 |
| Merck Sharp & Dohme LLC | 9 | $227 |
| Regeneron Healthcare Solutions, Inc. | 6 | $200 |
| Amgen Inc. | 6 | $158 |
| Viatris Specialty LLC | 7 | $148 |
| ANI Pharmaceuticals, Inc. | 5 | $96 |
Products named: DUPIXENT, Tyvaso, Ohtuvayre, WINREVAIR, FASENRA, TRELEGY ELLIPTA, YUPELRI, AIRSUPRA.
Industry payments across SC — which companies pay providers there.
